Navigation Links
Phase 2 Data From Oral NKTR-118 Presented at American College of Gastroenterology in San Diego
Date:10/27/2009

SAN DIEGO, Oct. 27 /PRNewswire-FirstCall/ -- Data from a phase II study demonstrated that oral NKTR-118 improved lower gastrointestinal dysfunction by increasing the frequency of bowel movements in patients with opioid-induced constipation, while simultaneously preserving opioid-mediated analgesia. NKTR-118, an oral peripherally-acting opioid antagonist, is an investigational product candidate in clinical development for the treatment of opioid-induced constipation.

(Logo: http://www.newscom.com/cgi-bin/prnh/20091027/PH99766LOGO )

In the phase II double blind, randomized, placebo-controlled study of 208 patients with opioid-induced constipation, NKTR-118 achieved the primary endpoint of change from baseline in spontaneous bowel movements (SBMs). Patients receiving either 25 mg or 50 mg of oral NKTR-118 once daily had a significantly greater change from baseline in SBMs during the first week of treatment than patients receiving placebo. The mean change from baseline in SBMs per week for patients receiving 25 mg NKTR-118 was 3.6 versus 1.9 in the placebo group (p= 0.002). Patients receiving 50 mg NKTR-118 had a mean change from baseline in SBMs per week of 4.4 versus 1.9 in the placebo group (p=0.0001). The increase from baseline in SBMs versus placebo averaged over the four-week treatment period was significant for both the 25 mg (p=0.002) and 50 mg (p<0.0001) dose groups. Results for the 5 mg dose of NKTR-118 were not significant.

The study also showed that there was a statistically significant difference in median time to first SBM for patients in the 25 mg and 50 mg dose cohorts as compared to placebo. Median time to first SBM for patients in the 25 mg dose cohort was 6.6 hours as compared to placebo which was 48.6 hours (p=0.001), and for patients in the 50 mg dose cohort, median time to first SBM was 2.9 hours as compared to placebo,
'/>"/>

SOURCE AstraZeneca
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Intercept Pharmaceuticals Announces Positive Phase II Results for INT-747 as a Treatment for Primary Biliary Cirrhosis
2. Horizon Therapeutics Presents Phase 3 Study Results Identifying Risk Factors for Ulcer Development Among NSAID Users
3. Biomoda Enters Final Stage of Patient Testing for Phase II Lung Cancer Clinical Study
4. Peregrine Pharmaceuticals Reports 61% Objective Response Rate in 46-Patient Bavituximab Phase II Trial in Advanced Breast Cancer
5. Delcath Systems, Inc. Completes Phase III Study Enrollment
6. AFFiRiS AG - Encouraging Results From Phase I Studies of two Alzheimers Candidate Vaccines Trigger a EUR 10 Million Milestone Payment
7. Transave Completes Successful Phase II Clinical Program for ARIKACE in the Treatment of Pseudomonas Lung Infections
8. Data from Jazz Pharmaceuticals First Phase III Study of Sodium Oxybate in Patients With Fibromyalgia to be Presented at Upcoming Conferences
9. Curemark Enrolls First Patients in Phase III Clinical Trials for Autism Treatment
10. Paratek Pharmaceuticals Signs Worldwide License and Commercialization Agreement for PTK 0796, Broad-Spectrum Oral and IV Antibiotic in Phase 3
11. TOPICA Announces Positive Phase 2 Clinical Results for Luliconazole, a Potent Topical Antifungal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... , FARUM, Denmark and ... On July 31, 2015 the US Food and Drug Administration ... of Major Depressive Disorder in adult patients who have failed ... current episode. TMS is a non-invasive technique for stimulating neural ... suffering from Major Depressive Disorder. The procedure has been proven ...
(Date:8/28/2015)... y LONDRES, 28 de agosto de ... PHIA) anunció hoy su participación en el  Congreso ... sus soluciones cardiológicas más recientes y novedosas, entre ... que conectan a las personas y la tecnología ... ayudar a diagnosticar, guiar los tratamientos y permitir ...
(Date:8/27/2015)... Aug. 27, 2015  A recent study by ... Journal, compared the Arthrosurface HemiCAP® Wave implant, which ... an "onlay" design implant for isolated patellofemoral disease. ... function and pain scores, none of the patients ... (OA). However, 53% of the patients in the ...
Breaking Medicine Technology:Therapy System for Treating Major Depressive Disorder Receives FDA Clearance 2Therapy System for Treating Major Depressive Disorder Receives FDA Clearance 3Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 2Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 3Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 4Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 5Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 2Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 3
(Date:8/28/2015)... ... 2015 , ... The Kentucky State Department of Workforce Investment Commissioner Beth Kuhn ... applying for, they are unable to pass the initial drug test and therefore unable ... in order to be able to hire long-term, skilled talent. (1) Will Wesch, Director ...
(Date:8/28/2015)... ... ... For Dallas, the time is nearing for the annual Heart Walk, and North ... American Heart Association hosts their well-known Heart Walk to raise money in awareness and ... be made. Walkers can participate in the cause and someone can also donate, even ...
(Date:8/28/2015)... ... 2015 , ... The 6th Annual Survivor in the City, Chicago silent ... another accolade to its cadre of widespread support—an official letter of support and gratitude ... the medical community and the University of Illinois at Chicago’s Department of Neurosurgery, the ...
(Date:8/28/2015)... ... August 28, 2015 , ... Saint Petersburg, FL —Pocket Protein™, ... fat, carbs, sugar, gluten, lactose or caffeine in a convenient 2 oz. pouch ... CPG Editor’s Choice Awards. , Five consumer packaged goods (CPG) products were selected ...
(Date:8/28/2015)... Boynton Beach, FL. (PRWEB) , ... August 28, ... ... creating problems for businesses nationwide. Addictions specialist, Dr. James Strawbridge, gives a new ... Strawbridge believes that it should begin with the employer and employees getting together ...
Breaking Medicine News(10 mins):Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 2Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 3Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 4Health News:North Central Surgical Center’s Subsidiary Participates in Walk 2Health News:Chicago Mayor Pens Official Support of Annual Survivor in the City Event Benefitting Brain Aneurysm Foundation 2Health News:Chicago Mayor Pens Official Support of Annual Survivor in the City Event Benefitting Brain Aneurysm Foundation 3Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 2Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 3
... ... founder of People-OnTheGo, released The Accomplishing More With Less Workbook paperback ... Results Curve™: How to Manage Focused and Collaborative Time”, which is ... enable business professionals to better manage the increasingly challenging work conditions ...
... , ... rates and other patient safety information in the public eye , ... in the Atlanta area vary in terms of how well ... death, disability, and expense in our nations, hospitals that is largely preventable. ...
... , New online hospital ... eye , YONKERS, N.Y. , Feb. 2 ... of how well their intensive care units (ICUs) prevent central-line bloodstream infections, ... is largely preventable.  On February 2 , www.ConsumerReportsHealth.org will ...
... , WATERBURY, Conn. , Feb. 2 ... new Kool Smiles office, which opened at 728 Wolcott Street, Waterbury, ... Waterbury opened its doors on January 22nd, 2010 ... families in the community of Waterbury .  Senator J. Hartley and ...
... ... SLI-Systems brings advanced Learning Search & Navigation to online health & beauty shoppers. ... (PRWEB) February 2, ... the Medichest.com platform. , , , , ,Learning Search tracks and “learns” customer ...
... ... new book "Stay Young: 10 Proven Steps to Ultimate Health". , ... Dallas, TX (PRWEB) February 2, 2010 -- Physicians are taking a ... With the ups and downs of the economy, many men are assumed to have depression ...
Cached Medicine News:Health News:People-OnTheGo Releases The Accomplishing More With Less Workbook Paperback, Kindle Edition and Free e-Book 2Health News:People-OnTheGo Releases The Accomplishing More With Less Workbook Paperback, Kindle Edition and Free e-Book 3Health News:Consumer Reports Health: Central-Line Infection Rates in Atlanta Hospitals Vary; One Hospital Reports Rates Up to 6 Times National Average; Some Hospitals Not Reporting 2Health News:Consumer Reports Health: Central-Line Infection Rates in Atlanta Hospitals Vary; One Hospital Reports Rates Up to 6 Times National Average; Some Hospitals Not Reporting 3Health News:Consumer Reports Health: Central-Line Infection Rates in Atlanta Hospitals Vary; One Hospital Reports Rates Up to 6 Times National Average; Some Hospitals Not Reporting 4Health News:Consumer Reports Health: Central-Line Infection Rates in Atlanta Hospitals Vary; One Hospital Reports Rates Up to 6 Times National Average; Some Hospitals Not Reporting 5Health News:Consumer Reports Health: Central-Line Infection Rates in Atlanta Hospitals Vary; One Hospital Reports Rates Up to 6 Times National Average; Some Hospitals Not Reporting 6Health News:Consumer Reports Health: Central-Line Infection Rates in Atlanta Hospitals Vary; One Hospital Reports Rates Up to 6 Times National Average; Some Hospitals Not Reporting 7Health News:Consumer Reports Health: Central-Line Infection Rates Vary in San Francisco Hospitals; Three Hospitals Report Zero Infections; Some Hospitals Not Reporting 2Health News:Consumer Reports Health: Central-Line Infection Rates Vary in San Francisco Hospitals; Three Hospitals Report Zero Infections; Some Hospitals Not Reporting 3Health News:Consumer Reports Health: Central-Line Infection Rates Vary in San Francisco Hospitals; Three Hospitals Report Zero Infections; Some Hospitals Not Reporting 4Health News:Consumer Reports Health: Central-Line Infection Rates Vary in San Francisco Hospitals; Three Hospitals Report Zero Infections; Some Hospitals Not Reporting 5Health News:Consumer Reports Health: Central-Line Infection Rates Vary in San Francisco Hospitals; Three Hospitals Report Zero Infections; Some Hospitals Not Reporting 6Health News:Consumer Reports Health: Central-Line Infection Rates Vary in San Francisco Hospitals; Three Hospitals Report Zero Infections; Some Hospitals Not Reporting 7Health News:Senator J. Hartley and Representatives Noujaim and Berger Celebrate Kool Smiles Opening in Waterbury 2Health News:Senator J. Hartley and Representatives Noujaim and Berger Celebrate Kool Smiles Opening in Waterbury 3Health News:Medichest Launches Learning Search 2Health News:American Men are Losing Their Vitality 2
... The AMS 700 Series is an advanced three-part ... the abdomen, a pump placed in the scrotum ... corpora cavernosa. It closely simulates the look and ... for innovative penile implant technology, the AMS 700 ...
Only Mentors reusable Alpine Leg Bag has patented Kraylex odor barrier, offset port options, and integrated loops providing total confidence and comfort....
... Freedom leg bags are part ... a versatile line of leg bags, ... the varied needs of our customers. ... several sizes, and constructed of 100% ...
... Freedom leg bags are part of ... versatile line of leg bags, kits, ... varied needs of our customers. These ... sizes, and constructed of 100% latex-free ...
Medicine Products: